Annual report pursuant to Section 13 and 15(d)

Provision for Income Taxes (Details Textual)

v3.20.1
Provision for Income Taxes (Details Textual)
12 Months Ended
Dec. 31, 2019
USD ($)
Provision for Income Taxes (Textual)  
Net operating loss carryforwards $ 26,700,000
Research and development tax credit carryforwards 197,747
Valuation allowance $ 1,357,874
Corporation rate, percentage 50.00%
Provision for income taxes, description Begin to expire in years 2035 and 2020, respectively. The Company also has estimated available research and development tax credit carryforwards for federal income tax purposes of $197,747, which begin to expire in year 2032.
Income tax, period P3Y